L501-1334 Screening compound: 1-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(thiophen-2-yl)methyl]piperidine-3-carboxamide

L501-1334 Screening compound: 1-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(thiophen-2-yl)methyl]piperidine-3-carboxamide
L501-1334 Screening compound: 1-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(thiophen-2-yl)methyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L501-1334
1-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(thiophen-2-yl)methyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L501-1334

Molecular Formula

C21H24N4O4S3 (C21 H24 N4 O4 S3)

Compound Name

1-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(thiophen-2-yl)methyl]piperidine-3-carboxamide

IUPAC name

1-{[4-(5-cyclobutyl-124-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(thiophen-2-yl)methyl]piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1S(c1cc(-c2noc(C3CCC3)n2)cs1)(=O)=O)NCc1cccs1

InChI

InChI=1S/C21H24N4O4S3/c26-20(22-11-17-7-3-9-30-17)15-6-2-8-25(12-15)32(27,28)18-10-16(13-31-18)19-23-21(29-24-19)14-4-1-5-14/h3,7,9-10,13-15H,1-2,4-6,8,11-12H2,(H,22,26)/t15-/m0/s1

InChI Key

HYRVSOQJJYFQMP-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD15128900

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.64

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.337

Distribution Coefficient, logD

3.337

Water Solubility, LogSw

-3.53

Polar Surface Area

90.262

Acid Dissociation Constant (pKa)

12.75

Base Dissociation Constant (pKb)

-2.38

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.60

L501-1334 in Drug Discovery

Included in Screening Libraries

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

SmartTM Library (51161 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with L501-1334 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L501-1334?
Check Price and Availability of L501-1334, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L501-1334 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L501-1334
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L501-1334
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L501-1334 available by request